Luca Issi

Q: What is Luca Issi's success rate?

Luca Issi currently has a success rate of 93.73712851777094.

Q: What is the average return of Luca Issi's calls?

Their stock ratings have generated an average return of 13.804401440621447.

RBC Capital | Healthcare

Luca Issi is an analyst from RBC Capital specializing in the Healthcare sector. Ranked #1453 out of 4771 analysts, they have issued 47 stock ratings with a success rate of 93.74% and an average return of 13.80%.

Luca Issi has a well-established track record, with 47 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.74% and an average return of 13.80%, underscoring their expertise and ability to identify winning opportunities for investors.

#1453

Out of 4771

Total Ratings

+93.74%

Success Rate

+13.80%

Average Return

Recent Ratings Analysis

DYN

Buy

Sep 09, 2026

Target

$35.00

Current

$18.42

Performance

-4.01%

Luca Issi rated DYN as Outperform on Sep 09, 2026, setting a price target of 35. Shares have remained stable near 18.42, leaving the 35 target still in play.

AMGN

Buy

Aug 05, 2026

Target

$400.00

Current

$382.47

Performance

-6.22%

On Aug 05, 2026, AMGN was given a Outperform rating by Luca Issi, with a target price of 400. Despite the Buy call, shares fell from 382.47 to 382.47, challenging the optimistic stance.

ALNY

Buy

Jul 31, 2026

Target

$350.00

Current

$247.51

Performance

20.43%

ALNY received a Outperform rating from Luca Issi on Jul 31, 2026, aiming for 350. Momentum has favored the Buy call, with shares climbing from 247.51 to 247.51, rewarding those who trusted the recommendation.

ARGX

Buy

Jul 24, 2026

Target

$1025.00

Current

$984.04

Performance

7.17%

On Jul 24, 2026, Luca Issi published a Outperform outlook on ARGX, with a target of 1025. Shares gained 7.17%, underscoring the accuracy of the bullish outlook toward 1025.

IONS

Buy

Jul 13, 2026

Target

$85.00

Current

$55.65

Performance

-1.94%

Luca Issi on Jul 13, 2026 assigned IONS a Outperform rating, with a price target of 85. The recommendation remains pending validation as shares consolidate around 55.65.

AGIO

Hold

Jul 07, 2026

Target

$32.00

Current

$33.64

Performance

-23.56%

On Jul 07, 2026, Luca Issi reaffirmed AGIO with a Sector Perform rating, targeting 32. The Hold stance reflected market caution that was later justified.

RARE

Buy

Jul 07, 2026

Target

$40.00

Current

$14.40

Performance

-59.86%

RARE was rated Outperform by Luca Issi on Jul 07, 2026, with a price objective of 40. This case shows how bullish projections can fail, with the stock now below 14.4.

MRNA

Hold

Jul 07, 2026

Target

$45.00

Current

$136.62

Performance

71.27%

On Jul 07, 2026, Luca Issi initiated coverage on MRNA with a Sector Perform rating and target of 45. The Hold stance underestimated the stock’s strength as it gained 71.27%.

BMRN

Hold

Jul 07, 2026

Target

$62.00

Current

$65.51

Performance

8.55%

Luca Issi issued a Sector Perform recommendation for BMRN on Jul 07, 2026, price target set at 62. A neutral call gave way to stronger-than-expected performance, closing in on 62.

ASND

Buy

Jul 07, 2026

Target

$280.00

Current

$261.23

Performance

-2.15%

On Jul 07, 2026, ASND was evaluated by Luca Issi, who gave a Outperform rating and target of 280. So far, the Buy call awaits clearer momentum, with shares flat at 261.23.

QURE

Buy

Jun 18, 2026

Target

$65.00

Current

$44.47

Performance

-3.93%

Luca Issi rated QURE as Outperform on Jun 18, 2026, setting a price target of 65. Shares have remained stable near 44.47, leaving the 65 target still in play.

ARWR

Buy

May 08, 2026

Target

$87.00

Current

$82.76

Performance

13.85%

On May 08, 2026, ARWR was given a Outperform rating by Luca Issi, with a target price of 87. The stock rallied 13.85% after the rating, narrowing the gap to the target of 87 and validating the bullish stance.

BBIO

Buy

Apr 09, 2026

Target

$100.00

Current

$72.50

Performance

-4.00%

BBIO received a Outperform rating from Luca Issi on Apr 09, 2026, aiming for 100. Price action was muted, as shares hovered around 72.5 despite the bullish outlook.

NTLA

Hold

Mar 03, 2026

Target

$15.00

Current

$11.93

Performance

-12.34%

On Mar 03, 2026, Luca Issi published a Sector Perform outlook on NTLA, with a target of 15. Weakness in the stock, now at 11.93, supported the conservative rating.

BEAM

Hold

Feb 25, 2026

Target

$26.00

Current

$24.37

Performance

-17.70%

Luca Issi on Feb 25, 2026 assigned BEAM a Sector Perform rating, with a price target of 26. The call successfully avoided chasing as shares lost 17.70%.

WVE

Buy

Dec 09, 2025

Target

$27.00

Current

$4.67

Performance

-78.09%

On Dec 09, 2025, Luca Issi reaffirmed WVE with a Outperform rating, targeting 27. Shares slid 78.09% despite the recommendation, highlighting downside risks.

FULC

Hold

Dec 08, 2025

Target

$10.00

Current

$3.80

Performance

-70.75%

FULC was rated Sector Perform by Luca Issi on Dec 08, 2025, with a price objective of 10. Investors who stayed cautious avoided some of the 70.75% decline.

KRRO

Hold

Nov 13, 2025

Target

$8.00

Current

$13.06

Performance

100.92%

On Nov 13, 2025, Luca Issi initiated coverage on KRRO with a Sector Perform rating and target of 8. The Hold stance underestimated the stock’s strength as it gained 100.92%.

CRSP

Hold

Nov 11, 2025

Target

$50.00

Current

$52.26

Performance

-5.34%

Luca Issi issued a Sector Perform recommendation for CRSP on Nov 11, 2025, price target set at 50. Market action validated the conservative Hold outlook with shares at 52.26.

RGNX

Buy

Nov 07, 2025

Target

$19.00

Current

$8.56

Performance

-23.64%

On Nov 07, 2025, RGNX was evaluated by Luca Issi, who gave a Outperform rating and target of 19. Investors saw limited payoff as shares fell short of the 19 target.

RNA

Hold

Oct 28, 2025

Target

$72.00

Current

$10.35

Performance

-85.20%

Luca Issi rated RNA as Sector Perform on Oct 28, 2025, setting a price target of 72. The cautious Hold call aligned with subsequent weakness, as shares slipped 85.20%.

LXEO

Buy

Mar 25, 2025

Target

$20.00

Current

$4.36

Performance

-1.80%

On Mar 25, 2025, LXEO was given a Outperform rating by Luca Issi, with a target price of 20. The stock traded sideways with a -1.80% move, keeping the bullish thesis unresolved.

SGMO

Hold

Mar 18, 2025

Target

$2.00

Current

$0.07

Performance

-91.25%

SGMO received a Sector Perform rating from Luca Issi on Mar 18, 2025, aiming for 2. The Hold stance proved prudent, with the market softening by 91.25%.

OCUL

Buy

Mar 18, 2025

Target

$17.00

Current

$10.62

Performance

42.55%

On Mar 18, 2025, Luca Issi published a Outperform outlook on OCUL, with a target of 17. Shares gained 42.55%, underscoring the accuracy of the bullish outlook toward 17.

MGTX

Buy

Mar 17, 2025

Target

$13.00

Current

$12.85

Performance

63.28%

Luca Issi on Mar 17, 2025 assigned MGTX a Outperform rating, with a price target of 13. The Buy call aligned well with market performance, producing a gain of 63.28%.

ALLO

Buy

Mar 14, 2025

Target

$10.00

Current

$1.76

Performance

-9.28%

On Mar 14, 2025, Luca Issi reaffirmed ALLO with a Outperform rating, targeting 10. Shares slid 9.28% despite the recommendation, highlighting downside risks.

VERV

Buy

Mar 04, 2025

Target

$15.00

Current

$11.13

Performance

81.86%

VERV was rated Outperform by Luca Issi on Mar 04, 2025, with a price objective of 15. A bullish response from the market helped close the gap of 3.87 to the target.

APLS

Hold

Mar 03, 2025

Target

$25.00

Current

$41.03

Performance

70.53%

On Mar 03, 2025, Luca Issi initiated coverage on APLS with a Sector Perform rating and target of 25. The Hold stance underestimated the stock’s strength as it gained 70.53%.

FDMT

Buy

Mar 03, 2025

Target

$35.00

Current

$13.49

Performance

225.85%

Luca Issi issued a Outperform recommendation for FDMT on Mar 03, 2025, price target set at 35. Investors following the Buy call captured upside momentum, with shares now at 13.49.

SLB

Buy

Jan 21, 2025

Target

$57.00

Current

$56.01

Performance

28.05%

On Jan 21, 2025, SLB was evaluated by Luca Issi, who gave a Outperform rating and target of 57. This case illustrates how a timely bullish rating can translate into tangible gains of 28.05%.

EDIT

Hold

Dec 13, 2024

Target

$4.00

Current

$2.65

Performance

84.03%

Luca Issi rated EDIT as Sector Perform on Dec 13, 2024, setting a price target of 4. Despite the Hold call, shares climbed 84.03% to 2.65, revealing unexpected momentum.

BLUE

Hold

Nov 15, 2024

Target

$80.00

Current

$4.97

Performance

-22.59%

On Nov 15, 2024, BLUE was given a Sector Perform rating by Luca Issi, with a target price of 80. The rating provided protection from downside risk as the stock fell to 4.97.

Frequency Asked Questions

Who is Luca Issi?

Luca Issi is an analyst from RBC Capital specializing in the Healthcare sector.

What is Luca Issi's success rate?

Luca Issi currently has a success rate of +93.74%.

How many ratings has Luca Issi issued?

Luca Issi has issued 47 stock ratings so far.

What is the average return of Luca Issi's calls?

Their stock ratings have generated an average return of +13.80%.

What is Luca Issi's ranking?

Luca Issi is ranked #1453 out of 4771 analysts.

What types of ratings does Luca Issi give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Luca Issi?

You can follow Luca Issi by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Luca Issi?

Their latest rating was a Buy on DYN issued on 2026-09-09.